Room temperature shipment does not affect the biological activity of pluripotent stem cell-derived retinal organoids.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 19 12 2019
accepted: 13 05 2020
entrez: 2 6 2020
pubmed: 2 6 2020
medline: 21 8 2020
Statut: epublish

Résumé

The generation of laminated and light responsive retinal organoids from induced pluripotent stem cells (iPSCs) provides a powerful tool for the study of retinal diseases and drug discovery and a robust platform for cell-based therapies. The aim of this study is to investigate whether retinal organoids can retain their morphological and functional characteristics upon storage at room temperature (RT) conditions and shipment by air using a commercially available container that maintains the environment at ambient temperature. Morphological analysis and measurements of neuroepithelial thickness revealed no differences between control, RT incubated and shipped organoids. Similarly immunohistochemical analysis showed no differences in cell type composition and position within the laminated retinal structure. All groups showed a similar response to light, suggesting that the biological function of retinal organoids was not affected by RT storage or shipment. These findings provide an advance in transport of ready-made retinal organoids, increasing their availability to many research and pharma labs worldwide and facilitating cross-collaborative research.

Identifiants

pubmed: 32479513
doi: 10.1371/journal.pone.0233860
pii: PONE-D-19-35134
pmc: PMC7263587
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0233860

Subventions

Organisme : Medical Research Council
ID : MR/T017503/1
Pays : United Kingdom
Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/C016106/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15030
Pays : United Kingdom

Déclaration de conflit d'intérêts

MG, BH, VC are paid employees of Newcells Biotech Ltd. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Eye (Lond). 2018 May;32(5):946-971
pubmed: 29503449
Cell Tissue Bank. 2015 Dec;16(4):553-8
pubmed: 25700692
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16698-703
pubmed: 19706890
Nat Commun. 2015 Feb 19;6:6286
pubmed: 25695148
Development. 2019 Jan 29;146(2):
pubmed: 30696714
Int J Pharm. 2005 Aug 11;299(1-2):49-54
pubmed: 15964724
Integr Med Res. 2017 Mar;6(1):12-18
pubmed: 28462139
J Tissue Eng Regen Med. 2020 Feb;14(2):388-394
pubmed: 31908157
Stem Cells. 2018 Oct;36(10):1535-1551
pubmed: 30004612
Acta Biomater. 2018 Jul 1;74:207-221
pubmed: 29777959
J Tissue Eng Regen Med. 2019 Mar;13(3):459-468
pubmed: 30644171
Stem Cells Transl Med. 2019 Jul;8(7):694-706
pubmed: 30916455
Cornea. 2013 Jan;32(1):63-9
pubmed: 23086365
Biomaterials. 2019 Apr;199:63-75
pubmed: 30738336
Front Cell Neurosci. 2019 Aug 07;13:361
pubmed: 31481876
Adv Drug Deliv Rev. 2019 Feb 1;140:33-50
pubmed: 29777757
Cell Tissue Bank. 2016 Dec;17(4):677-687
pubmed: 27562800

Auteurs

Maria Georgiou (M)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, England, United Kingdom.

Valeria Chichagova (V)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, England, United Kingdom.
Newcells Biotech Ltd, Newcastle upon Tyne, England, United Kingdom.

Gerrit Hilgen (G)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, England, United Kingdom.

Birthe Dorgau (B)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, England, United Kingdom.
Newcells Biotech Ltd, Newcastle upon Tyne, England, United Kingdom.

Evelyne Sernagor (E)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, England, United Kingdom.

Lyle Armstrong (L)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, England, United Kingdom.
Newcells Biotech Ltd, Newcastle upon Tyne, England, United Kingdom.

Majlinda Lako (M)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, England, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH